SCINAI IMMUNOTHERAPEUTICS LTD. Interest Expense On Lease Liabilities
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Interest Expense On Lease Liabilities of ILS 715.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-28.
Discontinued › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2022-03-28
ILS
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2021-12-31 | 715.00K ILS 20-F · filed 2022-03-28 |
| 2020-12-31 | 479.00K ILS 20-F · filed 2022-03-28 |
| 2019-12-31 | 676.00K ILS 20-F · filed 2021-05-13 |
USD
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2021-12-31 | $230.00K 20-F · filed 2022-03-28 |